Urokinase plasminogen activator and TGF-beta production in immunosuppressed patients with and without Pneumocystis carinii.
Angelici
E
E
Department of Clinical Medicine, University La Sapienza, Rome, Italy. Elena.angelici@uniroma1.it
Contini
C
C
Carfagna
P
P
Romani
R
R
Magno
M S
MS
Serra
P
P
Canipari
R
R
D017088:AIDS-Related Opportunistic Infections / Q000276:immunology*; D015658:HIV Infections / Q000276:immunology*; D006801:Humans; D016867:Immunocompromised Host; D009000:Monocytes / Q000276:immunology / Q000378:metabolism; D011010:Pneumocystis / Q000276:immunology; D011020:Pneumonia, Pneumocystis / Q000276:immunology*; D016212:Transforming Growth Factor beta / Q000378:metabolism*; D014568:Urokinase-Type Plasminogen Activator / Q000378:metabolism*
D016212:Transforming Growth Factor beta; D014568:Urokinase-Type Plasminogen Activator